Patents by Inventor Michel Dard

Michel Dard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11331167
    Abstract: Two part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. The soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: May 17, 2022
    Assignee: STRAUMANN HOLDING AG
    Inventors: Frank Schwarz, Jürgen Becker, Marco Wieland, Michel Dard
  • Publication number: 20190117344
    Abstract: Two part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. The soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.
    Type: Application
    Filed: December 18, 2018
    Publication date: April 25, 2019
    Applicant: STRAUMANN HOLDING AG
    Inventors: Frank SCHWARZ, Jürgen BECKER, Marco WIELAND, Michel DARD
  • Publication number: 20150086943
    Abstract: Two-part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. The soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.
    Type: Application
    Filed: September 2, 2014
    Publication date: March 26, 2015
    Applicant: STRAUMANN HOLDING AG
    Inventors: Frank Schwarz, Jurgen Becker, Marco Wieland, Michel Dard
  • Publication number: 20130196289
    Abstract: Two-part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. Said soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.
    Type: Application
    Filed: January 31, 2013
    Publication date: August 1, 2013
    Applicant: Straumann Holding AG
    Inventors: Frank Schwarz, Jurgen Becker, Marco Wieland, Michel Dard
  • Publication number: 20110312891
    Abstract: Isolated active compound of a naturally occurring fraction of Enamel Matrix Derivatives (EMD), having at least one of each two N-terminal polypeptide fragments of amelogenin, which are at least 95% identical to an amino acid sequence as shown in SEQ. ID. No:1 and/or 2. The invention relates to the use of said isolated active compound of a fraction and/or of the fraction itself, and/or the at least one of each two polypeptide fragments for use as a medicament and/or for the manufacture of a pharmaceutical composition for a variety of different medical indications such as inducing and/or promoting cementogenesis, bone growth and/or binding between parts of living mineralised tissue, for bonding of a piece of living mineralised tissue to a bonding site on a piece of other living tissue, for endorsing binding between hard tissues, for inducing regeneration of dentin, and/or for filling a mineralized wound cavity and/or tissue defect following from a procedure and/or trauma.
    Type: Application
    Filed: June 29, 2009
    Publication date: December 22, 2011
    Applicant: Straumann Holding AG
    Inventors: Stina Gestrelius, Michel Dard, Ruzica Ranevski, S. Petter Lyngstadaas, Corinna Mauth
  • Patent number: 8029283
    Abstract: Abutment of a dental implant system, having at the top a support region intended for receiving a prosthetic build-up construction and at the bottom an implant contact region intended for insertion into a receiving hole of an implant, and wherein the abutment has between the support region and the implant contact region a soft tissue contact surface. The soft tissue contact surface is at least partially hydroxylated or silanated.
    Type: Grant
    Filed: February 28, 2007
    Date of Patent: October 4, 2011
    Assignee: Straumann Holding AG
    Inventors: Frank Schwarz, Jürgen Becker, Marco Wieland, Michel Dard
  • Patent number: 7655624
    Abstract: The invention relates to compounds of formula (1) B-Q-X1, wherein B is bioactive cell adhesive mediating molecule. Q is absent or is an inorganic spacer molecule and X1 is an anchor molecule, selected from the group Lys-(CO—CH2—(CH2)n—PO3H2)2(I), -Lys-[-Lys-(CO—CH2—(CH2)a—PO3H2)2]2(ii) or -Lys-(Lys[-Lys-(CO—CH2—(CH2)n—PO3H2]2 (iii), and n independently represents 0, 1, 2 or 3, wherein a free amino group of group B is linked in peptide form to a free carboxyl group of the spacer molecule Q or of the anchor molecule X1, or a free amino group of the radical Q is linked in peptide form to a free carboxyl group of the radical X1. The invention also relates to the salts thereof.
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: February 2, 2010
    Assignee: Biomet Deutschland GmbH
    Inventors: Joerg Meyer, Berthold Nies, Michel Dard, Guenter Hoelzemann, Horst Kessler, Martin Kantlehner, Ulrich Hersel, Christoph Gibson, Gabor Sulyok
  • Patent number: 7276482
    Abstract: The invention relates to compounds of formula (I) B-Q-X1, wherein B is a bioactive, cell adhesive mediating molecule, selected from the group (i) and Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (SEQ ID NO: 1) (ii), Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (SEQ ID NO: 2) (iii), Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (SEQ ID NO: 3) (iv), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg (SEQ ID NO: 4) (v), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn (SEQ ID NO: 5) (vi), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg (SEQ ID NO: 6) (vii), wherein (i) X, Y, Z, R2, R3, R4, A, Ar, Hal, Het, Het1, n, m, o, p, q, s, t have the meanings cited in claim 1, Q is absent or is an organic spacer molecule, X1 is an anchor molecule selected from the group cited in claim 1, and the salts thereof, which can be used as integrin inhibitors particularly for treatment of illness, deficiencies and inflammations caused by implants and osteolytic illnesses such as osteoporosis, thrombosis, cardiac infarction and arteriosclerosis, in addition to th
    Type: Grant
    Filed: August 2, 2001
    Date of Patent: October 2, 2007
    Assignee: Biomet Deutschland GmbH
    Inventors: Joerg Meyer, Berthold Nies, Michel Dard, Guenter Hoelzemann, Horst Kessler, Martin Kantlehner, Ulrich Hersel, Christoph Gibson, Gabor Sulyok
  • Publication number: 20070202462
    Abstract: Abutment of a dental implant system, having at the top a support region intended for receiving a prosthetic build-up construction and at the bottom an implant contact region intended for insertion into a receiving hole of an implant, and wherein the abutment has between the support region and the implant contact region a soft tissue contact surface. Said soft tissue contact surface is at least partially hydroxylated or silanated.
    Type: Application
    Filed: February 28, 2007
    Publication date: August 30, 2007
    Applicant: Straumann Holding AG
    Inventors: Frank Schwarz, Jurgen Becker, Marco Wieland, Michel Dard
  • Publication number: 20070202464
    Abstract: One-part implant for attachment of artificial teeth comprising an anchoring part and a mounting part, wherein the anchoring part and the mounting part are configured in one piece. The anchoring part of the one-part implant has a bone contact surface B and a soft tissue contact surface S. The soft tissue contact surface S is at least partially hydroxylated or silanated, which results in an improved soft tissue integration.
    Type: Application
    Filed: February 28, 2007
    Publication date: August 30, 2007
    Applicant: Straumann Holding AG
    Inventors: Frank Schwarz, Jurgen Becker, Marco Wieland, Michel Dard
  • Publication number: 20070202466
    Abstract: Two-part implant for attachment of artificial teeth comprising a base body having a bone contact surface and a soft tissue contact surface. Said soft tissue contact surface is at least partially hydroxylated or silanated which results in an improved soft tissue integration.
    Type: Application
    Filed: February 28, 2007
    Publication date: August 30, 2007
    Applicant: Straumann Holding AG
    Inventors: Frank Schwarz, Jurgen Becker, Marco Wieland, Michel Dard
  • Patent number: 7229545
    Abstract: A biomimetically produced bone-analogous coating, comprising organic and inorganic main constituents, is suitable for coating metallic implant materials of any desired surfaces. The coating comprises a collagen matrix mineralized with calcium phosphate.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: June 12, 2007
    Assignee: Biomet Deutschland GmbH
    Inventors: Andreas Sewing, Michel Dard, Sophie Roessler, Dieter Scharnweber, Hartmut Worch
  • Publication number: 20040043937
    Abstract: The invention relates to compounds of formula (I) B-Q-X1, wherein B is a bioactive, cell adhesive mediating molecule, selected from the group (i) and Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (ii), Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (iii), Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (iv), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg (v), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn (vi), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg (vii), wherein (i) X, Y, Z, R2, R3, R4, A, Ar, Hal, Het, Het1, n, m, o, p, q, s, t have the meanings cited in claim 1, Q is absent or is an organic spacer molecule, X1 is an anchor molecule selected from the group cited in claim 1, and the salts thereof, which can be used as integrin inhibitors particularly for treatment of illness, deficiencies and inflammations caused by implants and osteolytic illnesses such as osteoporosis, thrombosis, cardiac infarction and arteriosclerosis, in addition to the acceleration and strengthening of the integration process of implants or the biocompatib
    Type: Application
    Filed: February 14, 2003
    Publication date: March 4, 2004
    Inventors: Jorg Meyer, Berthold Nies, Michel Dard, Gunter Holzemann, Horst Kessler, Martin Kantlehner, Ulrich Hersel, Christoph Gibson, Gabor Sulyok
  • Publication number: 20040033249
    Abstract: A biomimetically produced bone-analogous coating, comprising organic and inorganic main constituents, is suitable for coating metallic implant materials of any desired surfaces. The coating comprises a collagen matrix mineralized with calcium phosphate.
    Type: Application
    Filed: April 16, 2003
    Publication date: February 19, 2004
    Applicant: Merck Patent Gesellschaft mit Beschrankter Haftung
    Inventors: Andreas Sewing, Michel Dard, Sophie Roessler, Dieter Scharnweber, Hartmut Worch
  • Publication number: 20040029782
    Abstract: The invention relates to compounds of formula (1) I-Q-X1, wherein B is bioactive cell adhesive mediating molecule. Q is absent or is an inorganic spacer molecule and X1 is an anchor molecule, selected from the group Lys.(CO—CH —(CH2)n—PO3H2)2(I)-Lys[-Lys-(CO—CH2—(CH2)a—PO3H2)2]2(ii) or -Lys-(Lys[-Lys-(CO—CH2—(CH2)n—PO3H2]2 (iii), and n independently represents 0, 1, 2 or 3, wherein a free amino group of group B is linked in peptide form to a free carboxyl group of the spacer molecule Q or of the anchor molecule X1 or a free amino group of the radical Q is linked in peptide form to a free carboxyl group of the radical X1. The invention also relates to the salts thereof.
    Type: Application
    Filed: February 14, 2003
    Publication date: February 12, 2004
    Inventors: J?ouml;rg Meyer, Berthold Nies, Michel Dard, Gunter Holzemann, Horst Kessler, Martin Kantlehner, Ulrich Hersel, Christoph Gibson, Gabor Sulyok
  • Publication number: 20020018798
    Abstract: A biomimetically produced bone-analogous coating, comprising organic and inorganic main constituents, is suitable for coating metallic implant materials of any desired surfaces. The coating comprises a collagen matrix mineralized with calcium phosphate.
    Type: Application
    Filed: June 21, 2001
    Publication date: February 14, 2002
    Applicant: Merck Patent Gesellschaft mit Beschrankter Haftung
    Inventors: Andreas Sewing, Michel Dard, Sophie Rossler, Dieter Scharnweber, Hartmut Worch
  • Patent number: 5762499
    Abstract: A dental root implant has a metal implant body which has transverse openings near its rounded lower end. The implant body has a shape which tapers downwards. Circumferential grooves are arranged parallel and mutually separated in its outer face, the grooves being rounded at their bases and at the junctions with neighboring outer face sections.
    Type: Grant
    Filed: June 21, 1996
    Date of Patent: June 9, 1998
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Michel Dard, Gerard De Witte, Philippe Rouvre